Skip to main content
. Author manuscript; available in PMC: 2013 Feb 25.
Published in final edited form as: J Am Coll Cardiol. 2009 Dec 8;54(24):2277–2286. doi: 10.1016/j.jacc.2009.06.055

Figure 3. Increase From Baseline Values in Percent LVEF at 3 and 6 Months Post-Treatment in Patients With Anterior MI.

Figure 3

Human mesenchymal stem cells = solid bars (n = 17 at 3 months, n = 15 at 6 months); placebo = open bars (n = 10 at 3 months, n = 9 at 6 months). *p = 0.0436 at 6 months for human mesenchymal stem cell-treated patients versus baseline, analysis of variance. LVEF = left ventricular ejection fraction; MI = myocardial infarction.